A new director general has been appointed to lead the Irish Venture Capital Association (IVCA).
Sarah-Jane Larkin replaces Regina Breheny who has taken up another role in financial services.
Peter Sandys, chairman of the IVCA commented: “We are delighted to attract someone of the calibre of Sarah-Jane to replace Regina who, over 14 years, has contributed hugely the growth of the venture capital business in Ireland. The IVCA would like to put on record our thanks and appreciation of Regina’s contribution.”
Larkin, previously commercial director of pharma giant MSD in Ireland, has worked at director level in the healthcare and medical device sectors for over a decade at organistions like J&J, Sisk Healthcare and the Irish Medical & Surgical Trade Association.
A graduate of UCD, she holds an MBA from Smurfit Business School.
Scaling up indigenous tech players
The Irish Venture Capital Association is the representative organisation for venture capital firms in Ireland.
Since the onset of the credit crunch in 2008, more than 1,450 Irish SMEs raised venture capital of €3.6bn.
The majority of this investment came from Irish venture capital fund managers who during this period supported the creation of up to 20,000 jobs; attracted over €1.6bn of capital into Ireland and geared up the State’s investment through the Seed & Venture Capital Programme by almost 16 times.
Commenting on her new appointment, Larkin said that now more than ever is the time to help local tech firms scale up.
“At a time of huge global change it is more important than ever for Ireland to accelerate the development of indigenous high potential companies and the IVCA has a critical role to play in this.”
The post Sarah-Jane Larkin named new DG of Irish Venture Capital Association appeared first on Silicon Republic.